Biophytis (EPA:ALBPS) | WebDisclosure

BRIEF

published on 08/03/2026 at 07:05, 3 days 15 hours ago

Biophytis : Perspectives de sa Co-entreprise à Hong Kong

Biophytis Financement Sarcopénie Phase 3 Co-entreprise
BRIEF

published on 08/03/2026 at 07:05, 3 days 15 hours ago

Biophytis Updates on Hong Kong Joint Venture Progress

Biophytis Joint Venture Clinical Trial Sarcopenia BIO101
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 3 days 15 hours ago

Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Biophytis présente les avancées de sa co-entreprise à Hong Kong et ses perspectives de développement à court et moyen terme dans le domaine de la longévité

Biophytis Développement Hong Kong Sarcopénie Co-entreprise
REGULATED PRESS RELEASE

published on 08/03/2026 at 07:00, 3 days 15 hours ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including intellectual property transfer, funding details, and clinical trial preparations

Biophytis Joint Venture Hong Kong Intellectual Property Clinical Trial
PRESS RELEASE

published on 08/03/2026 at 06:59, 3 days 15 hours ago

Biophytis fait un point d’étape et partage les perspectives de sa co-entreprise à Hong Kong
Biophytis fait un point d'étape sur sa co-entreprise à Hong Kong et partage ses perspectives à court et moyen terme, notamment le déploiement de BIO101 et la phase 3 dans la sarcopénie

Biophytis Hong Kong Sarcopénie BIO101 Co-entreprise
PRESS RELEASE

published on 08/03/2026 at 06:59, 3 days 15 hours ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including key milestones achieved and imminent progress. The joint venture aims to develop BIO101 for sarcopenia in Asian markets

Biophytis Joint Venture Hong Kong Sarcopenia BIO101
BRIEF

published on 07/29/2026 at 23:05, 7 days 23 hours ago

Biophytis : Publication des comptes annuels 2025 et reprise de la cotation

Biophytis Trésorerie Cotation Boursière Incertitude Financière Résultats Financiers 2025
BRIEF

published on 07/29/2026 at 23:05, 7 days 23 hours ago

Biophytis Reports Audited 2025 Financial Results and Stock Trading Resumption

Financial Results Biophytis Trading Resumption 2025 Audit Funding Uncertainty
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 7 days 23 hours ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de sa cotation sur Euronext Growth Paris. Les résultats financiers montrent une amélioration malgré une perte nette de 8,2 M€

Résultats Financiers Biophytis Cotation Comptes Annuels Perte Nette
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 7 days 23 hours ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024

Financial Statements Biophytis Financial Debt Trading Resumption Liabilities

Published on 08/06/2026 at 22:05, 11 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 16 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 15:00, 7 hours 16 minutes ago

Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 14:30, 7 hours 46 minutes ago

Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook
Published on 08/06/2026 at 14:30, 7 hours 46 minutes ago

NV Gold Announces Expansion of Holdings and Drill Program at the Slumber Gold Project in Nevada

View all ACCESSWIRE

Published on 08/06/2026 at 21:45, 30 minutes ago

FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 3 hours 10 minutes ago

Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 3 hours 51 minutes ago

EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:15, 4 hours 1 minute ago

BIOSYNEX SA: Cyberattaque
Published on 08/06/2026 at 17:34, 4 hours 42 minutes ago

Issue of Equity

View all EQS

Published on 08/06/2026 at 18:26, 3 hours 50 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 3 hours 50 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 4 hours 30 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 4 hours 31 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 4 hours 31 minutes ago

Declaration of voting rights at the end of July 2026

View all LES ECHOS COMFI WIRE

News